Hemodynamic effects of a kinin antagonist

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Endogenous kinins play a role in blood pressure regulation.
• Angiotensin II is a potent vasoconstrictor influencing blood pressure.

Purpose of the Study:

• To investigate the effect of a specific kinin antagonist on blood pressure, heart rate, and splanchnic nerve activity in rats.
• To determine the interaction between kinins and angiotensin II in blood pressure control.
• To assess the impact of angiotensin-converting enzyme (ACE) inhibition on this interaction.

Main Methods:

• Administration of a kinin antagonist (D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-trifluoroacetic acid) via intra-arterial infusion in unanesthetized rats.
• Pre-infusion with angiotensin II to establish a baseline for assessing the antagonist's effect.
• Measurement of blood pressure, heart rate, and splanchnic nerve activity.
• Acute blockade of angiotensin-converting enzyme (ACE) using captopril.

Main Results:

• The kinin antagonist alone did not affect blood pressure in control rats.
• In rats pre-infused with angiotensin II, the kinin antagonist significantly increased blood pressure.
• This blood pressure increase was not linked to changes in splanchnic nerve activity.
• Captopril (ACE inhibitor) did not alter the pressor response to the kinin antagonist in angiotensin II-treated rats.

Conclusions:

• Endogenous kinins appear to attenuate the vasoconstrictor effects of angiotensin II, thereby participating in blood pressure regulation.
• The interaction between kinins and angiotensin II in blood pressure control is not potentiated by acute ACE inhibition.